Zobrazeno 1 - 10
of 1 011
pro vyhledávání: '"Rodriguez Otero, P."'
Autor:
Solomey, Nickolas, Christl, Mark, Doty, Brian, Folkerts, Jonathan, Hartsock, Brooks, Kuznetsco, Evgen, McTaggart, Robert, Meyer, Holger, Nolan, Tyler, Pawloski, Greg, Reichart, Daniel, Rodriguez-Otero, Miguel, Smith, Dan, Solomey, Lisa
We have developed a neutrino detector with threshold energies from ~0.115 to 105 MeV in a clean detection mode almost completely void of accidental backgrounds. It was initially developed for the NASA $\nu$SOL project to put a solar neutrino detector
Externí odkaz:
http://arxiv.org/abs/2411.05615
Autor:
Doty, Brian, Solomey, Nickolas, Folkerts, Jonathan, Hartsock, Brooks, Meyer, Holger, Christl, Mark, Rodriguez-Otero, Miguel, Kuznetsov, Evgeny
A CubeSat with a prototype scintillating detector with a sensitive volume of GAGG crystal is being developed with a possible launch date of 2025. Its purpose is to characterize the background signals that mimic the neutrino interaction that the nuSOL
Externí odkaz:
http://arxiv.org/abs/2405.04659
Autor:
Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesus F. San-Miguel, Paula Rodriguez-Otero, Bruno Paiva, the Asociación Vasco-Navarra de Hematología y Hemoterapia (ASOVASNA) cooperative group
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Infection is the leading cause of death in multiple myeloma (MM). However, the cellular composition associated with immune dysfunction is not defined. We analyzed immune profiles in the peripheral blood of patients with MM (n = 28) and B-cel
Externí odkaz:
https://doaj.org/article/d290946f1de348f38a26beba2fae6800
Autor:
Paula Rodriguez-Otero, Thomas Martin
Publikováno v:
Hemato, Vol 5, Iss 2, Pp 171-179 (2024)
The treatment of relapsed and refractory multiple myeloma has improved substantially in the last 5–10 years based on the development and use of several novel classes of drugs and drug combinations. These advances have led to improvements in progres
Externí odkaz:
https://doaj.org/article/f1fcc3e73eef4e409a17047281c1673a
Autor:
Nahia Gómez-Echarte, Edurne San José-Enériz, Arantxa Carrasco-León, Naroa Barrena, Estibaliz Miranda, Leire Garate, Beatriz García-Torre, Sandra Alonso-Moreno, Naroa Gimenez-Camino, Estibaliz Urizar-Compains, Danel Olaverri-Mendizabal, Paula Aguirre-Ruiz, Beñat Ariceta, Luis-Esteban Tamariz-Amador, Paula Rodriguez-Otero, Francisco J. Planes, Laura Belver, José Ignacio Martín-Subero, Felipe Prosper, Xabier Agirre
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/d9ad4eb37a8149279d2b82a9df1dfc5d
Autor:
A. Medina-Herrera, I. Vazquez, I. Cuenca, J. M. Rosa-Rosa, B. Ariceta, C. Jimenez, M. Fernandez-Mercado, M. J. Larrayoz, N. C. Gutierrez, M. Fernandez-Guijarro, V. Gonzalez-Calle, P. Rodriguez-Otero, A. Oriol, L. Rosiñol, A. Alegre, F. Escalante, J. De La Rubia, A. I. Teruel, F. De Arriba, M. T. Hernandez, J. Lopez-Jimenez, E. M. Ocio, N. Puig, B. Paiva, J. J. Lahuerta, J. Bladé, J. F. San Miguel, M. V. Mateos, J. Martinez-Lopez, M. J. Calasanz, R. Garcia-Sanz, GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Smoldering multiple myeloma (SMM) precedes multiple myeloma (MM). The risk of progression of SMM patients is not uniform, thus different progression-risk models have been developed, although they are mainly based on clinical parameters. Rece
Externí odkaz:
https://doaj.org/article/1a994d26019e41bc8d283f1ab8ab67d5
Autor:
Paula Rodriguez-Otero, Niels W. C. J. van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Philippe Moreau, Nizar Bahlis, Ajai Chari
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Multiple myeloma is a genetically complex and heterogenous malignancy with a 5-year survival rate of approximately 60%. Despite advances in therapy, patients experience cycles of remission and relapse, with each successive line of therapy as
Externí odkaz:
https://doaj.org/article/3ef6305f5c894c229cdfe5cd8505447b
Autor:
Michael H. Tomasson, Shinsuke Iida, Ruben Niesvizky, Mohamad Mohty, Nizar J. Bahlis, Joaquin Martinez‐Lopez, Guenther Koehne, Paula Rodriguez‐Otero, H. Miles Prince, Andrea Viqueira, Eric Leip, Umberto Conte, Sharon T. Sullivan, Alexander M. Lesokhin
Publikováno v:
HemaSphere, Vol 8, Iss 7, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/27acdb8a010440b88549a06b1099d30e
Autor:
Marc S. Raab, Elena Zamagni, Salomon Manier, Paula Rodriguez‐Otero, Fredrik Schjesvold, Annemiek Broijl
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1117-1131 (2023)
Abstract Overall outcomes for multiple myeloma have improved due to the availability of new therapies, but patients with relapsed/refractory multiple myeloma harbouring certain factors continue to pose a therapeutic challenge. These challenging featu
Externí odkaz:
https://doaj.org/article/8a6c23a03654471990d390e4f8fa5147
Autor:
Maria Victoria Mateos, Katja Weisel, Evangelos Terpos, Sossana Delimpasi, Efstathios Kastritis, Elena Zamagni, Michel Delforge, Enrique Ocio, Eirini Katodritou, Francesca Gay, Alessandra Larocca, Xavier Leleu, Paula Rodriguez Otero, Fredik Schjesvold, Michele Cavo, Meletios A. Dimopoulos
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/d32b963c3bd94ba795f5046d7984d202